|
|||||
|
|

Data analytics and digital solutions company ExlService Holdings (NASDAQ:EXLS) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12.2% year on year to $529.6 million. The company expects the full year’s revenue to be around $2.08 billion, close to analysts’ estimates. Its non-GAAP profit of $0.48 per share was 3.2% above analysts’ consensus estimates.
Is now the time to buy EXLS? Find out in our full research report (it’s free for active Edge members).
EXL’s third quarter results were met with a negative market reaction despite outperforming Wall Street’s revenue and non-GAAP earnings expectations. Management pointed to accelerated adoption of its data and AI-led solutions, which now comprise over half of total revenue, as a primary driver of growth. CEO Rohit Kapoor emphasized, “Our data and AI-led revenue grew 18% year-over-year, reaching 56% of total revenue,” highlighting increased client demand for AI-powered workflow transformation. The Insurance, Healthcare and Life Sciences, and Banking segments all contributed to top-line gains, with particular strength in Healthcare.
Looking forward, management’s revised outlook is built on continued expansion in data and AI services, a strong recurring revenue base, and a pipeline of new client wins. Kapoor stated that EXL’s visibility into upcoming quarters is supported by high renewal rates and healthy demand, adding, “We have momentum to sustain double-digit top line growth into 2026.” Investments in front-end sales, capability development, and the rollout of the EXLdata.ai platform are expected to support both growth and margin improvement, though management acknowledged that spending will remain elevated to capture these opportunities.
Management attributed Q3’s solid growth to increased demand for AI-enabled solutions, robust performance in Healthcare, and a strategic shift toward embedding AI across traditional digital operations.
EXL expects continued growth to be fueled by rising enterprise adoption of AI-enabled solutions, a stable base of recurring revenue, and targeted investments in sales and capability development.
Over the coming quarters, the StockStory team will be watching (1) the pace of adoption and monetization for the new EXLdata.ai platform and related AI services, (2) whether international markets and Healthcare sustain their current growth trajectories, and (3) the balance between investment in front-end sales and margin improvement. Additionally, client wins and expansion of recurring, high-value contracts will be critical indicators of execution.
EXL currently trades at $38.16, down from $41.47 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free for active Edge members).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Nov-13 | |
| Nov-06 | |
| Nov-06 | |
| Nov-05 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Oct-31 | |
| Oct-30 | |
| Oct-29 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite